Skip to content

Clinical trials

Observational Heart Valve Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Valve Diseases Phase: Observational Clear all

227 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20054
20065
20074
20088
20092
20106
20116
20123
20134
20144
201511
20168
201712
201811
201913
20209
202122
202220
202321
202416
202517
202620

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78
Recruiting59
Unknown status48
Not yet recruiting18
Active, not recruiting9
Terminated8
Withdrawn5
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Affiliated Hospital, Zhejiang University, School of Medicine7
Shanghai Zhongshan Hospital5
Abbott Medical Devices4
Assiut University4
Yonsei University4
Centre Chirurgical Marie Lannelongue3
China National Center for Cardiovascular Diseases3
Edwards Lifesciences3
Mayo Clinic3
The Cleveland Clinic3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Valve Diseases227
Heart Failure34
Aortic Valve Stenosis30
Cardiovascular Diseases25
Coronary Artery Disease23
Heart Diseases21
Mitral Valve Insufficiency20
Tricuspid Valve Insufficiency19
Atrial Fibrillation18
Aortic Valve Insufficiency14

Trials

Showing 76 to 100 of 227. Each trial links to its page on Pharma Observatory.

127 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.